NRC - National Research Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Lincoln,
United States
Type: Equity
NRC price evolution
NRC
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.65 | $3.83 | $22.5 | $23.72 |
| Short term investments | ||||
| Net receivables | $12.38 | $14.47 | $11.89 | $14.22 |
| Inventory | ||||
| Total current assets | $24.36 | $24.74 | $40.99 | $45.17 |
| Long term investments | ||||
| Property, plant & equipment | $30.27 | $26.75 | $22.95 | $19.94 |
| Goodwill & intangible assets | $63.09 | $63.12 | $63.16 | $63.19 |
| Total noncurrent assets | $98.08 | $95.39 | $92.64 | $89.13 |
| Total investments | ||||
| Total assets | $122.44 | $120.14 | $133.63 | $134.31 |
| Current liabilities | ||||
| Accounts payable | $1.3 | $1.42 | $2.15 | $1.38 |
| Deferred revenue | $14.83 | $16.24 | $14.83 | $15.9 |
| Short long term debt | $7.21 | $9.66 | $4.61 | $4.55 |
| Total current liabilities | $36.2 | $40.8 | $33.74 | $36.11 |
| Long term debt | $29.47 | $14.16 | $15.36 | $16.53 |
| Total noncurrent liabilities | $37.28 | $21.46 | $22.14 | $23.53 |
| Total debt | $36.68 | $23.83 | $19.96 | $21.08 |
| Total liabilities | $73.48 | $62.26 | $55.88 | $59.64 |
| Shareholders' equity | ||||
| Retained earnings | -$30.53 | -$36.48 | -$16.85 | -$21.17 |
| Other shareholder equity | ||||
| Total shareholder equity | $48.95 | $57.87 | $77.75 | $74.67 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.65 | $25.03 | $54.36 | $34.69 |
| Short term investments | ||||
| Net receivables | $12.38 | $15.3 | $13.73 | $13.92 |
| Inventory | ||||
| Total current assets | $24.36 | $43.72 | $73.71 | $54.11 |
| Long term investments | ||||
| Property, plant & equipment | $30.27 | $17.8 | $13.37 | $13.03 |
| Goodwill & intangible assets | $63.09 | $63.23 | $63.4 | $58.66 |
| Total noncurrent assets | $98.08 | $86.75 | $83.83 | $79.31 |
| Total investments | ||||
| Total assets | $122.44 | $130.46 | $157.54 | $133.42 |
| Current liabilities | ||||
| Accounts payable | $1.3 | $1.15 | $1.94 | $1.09 |
| Deferred revenue | $14.83 | $15.2 | $17.21 | $15.59 |
| Short long term debt | $7.21 | $4.49 | $4.28 | $4.06 |
| Total current liabilities | $36.2 | $33.42 | $40.39 | $31.68 |
| Long term debt | $29.47 | $17.73 | $22.27 | $26.55 |
| Total noncurrent liabilities | $37.28 | $25.01 | $31.82 | $37.43 |
| Total debt | $36.68 | $22.18 | $26.55 | $30.61 |
| Total liabilities | $73.48 | $58.43 | $72.2 | $69.11 |
| Shareholders' equity | ||||
| Retained earnings | -$30.53 | -$25.18 | -$36.11 | -$61.38 |
| Other shareholder equity | -$2.38 | -$2.4 | ||
| Total shareholder equity | $48.95 | $72.03 | $85.34 | $64.31 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $37.95 | $36.16 | $36.47 | |
| Cost of revenue | $14.63 | $13.31 | $14.28 | |
| Gross Profit | $23.31 | $22.85 | $22.19 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $11.8 | $11.97 | $11.78 | |
| Total operating expenses | $13.36 | $13.49 | $13.18 | |
| Operating income | $9.96 | $9.37 | $9.02 | |
| Income from continuing operations | ||||
| EBIT | $10.2 | $9.64 | $9.25 | |
| Income tax expense | $2.16 | $2.17 | $2.05 | |
| Interest expense | $0.16 | $0.19 | $0.24 | |
| Net income | ||||
| Net income | $7.88 | $7.27 | $6.96 | |
| Income (for common shares) | $7.88 | $7.27 | $6.96 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $148.58 | $151.57 | $147.95 | $133.28 |
| Cost of revenue | $56.02 | $57.05 | $52.35 | $49.19 |
| Gross Profit | $92.56 | $94.52 | $95.6 | $84.09 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $46.62 | $42.7 | $38.96 | $34.44 |
| Total operating expenses | $52.52 | $47.98 | $45.33 | $41.41 |
| Operating income | $40.05 | $46.54 | $50.27 | $42.68 |
| Income from continuing operations | ||||
| EBIT | $40.82 | $44.02 | $50.29 | $43.28 |
| Income tax expense | $8.99 | $11.02 | $11.15 | $4.21 |
| Interest expense | $0.86 | $1.21 | $1.67 | $1.81 |
| Net income | ||||
| Net income | $30.97 | $31.8 | $37.47 | $37.26 |
| Income (for common shares) | $30.97 | $31.8 | $37.47 | $37.26 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $8.86 | $7.88 | $7.27 | $6.96 |
| Operating activities | ||||
| Depreciation | $1.43 | $1.55 | $1.52 | $1.39 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.26 | $0.07 | $0.3 | $0.3 |
| Total cash flows from operations | $11.71 | $9.82 | $8.84 | $7.75 |
| Investing activities | ||||
| Capital expenditures | -$3.77 | -$4.47 | -$4.34 | -$3.2 |
| Investments | ||||
| Total cash flows from investing | -$3.77 | -$4.47 | -$4.34 | -$3.2 |
| Financing activities | ||||
| Dividends paid | -$2.95 | -$27.51 | -$2.95 | -$2.96 |
| Sale and purchase of stock | -$15 | -$0.31 | -$1.54 | -$1.67 |
| Net borrowings | $12.83 | $3.81 | -$1.24 | -$1.23 |
| Total cash flows from financing | -$5.11 | -$24.02 | -$5.72 | -$5.86 |
| Effect of exchange rate | -$0 | |||
| Change in cash and equivalents | $2.83 | -$18.67 | -$1.23 | -$1.3 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $30.97 | $31.8 | $37.47 | $37.26 |
| Operating activities | ||||
| Depreciation | $5.9 | $5.28 | $6.37 | $7.5 |
| Business acquisitions & disposals | -$3 | |||
| Stock-based compensation | $0.94 | $1.2 | $0.62 | $0.68 |
| Total cash flows from operations | $38.11 | $36.27 | $46.34 | $40.64 |
| Investing activities | ||||
| Capital expenditures | -$15.78 | -$9.84 | -$5.51 | -$3.98 |
| Investments | ||||
| Total cash flows from investing | -$15.78 | -$9.84 | -$8.51 | -$3.72 |
| Financing activities | ||||
| Dividends paid | -$36.37 | -$20.96 | -$9.16 | -$10.52 |
| Sale and purchase of stock | -$18.52 | -$27.62 | -$3.7 | $1.73 |
| Net borrowings | $14.17 | -$4.87 | -$4.59 | -$3.94 |
| Total cash flows from financing | -$40.71 | -$55.58 | -$18.16 | -$15.5 |
| Effect of exchange rate | -$0 | -$0.18 | $0 | -$0.24 |
| Change in cash and equivalents | -$18.37 | -$29.34 | $19.67 | $21.17 |
News
Fundamentals
| Market cap | $813.55M |
|---|---|
| Enterprise value | $843.58M |
| Shares outstanding | 24.22M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 16.62 |
| Book/Share | 2.02 |
| Cash/Share | 0.27 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.50 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.67 |
| Quick ratio | 0.67 |